{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:12:53Z","timestamp":1793653973762,"version":"4.5.1"},"reference-count":95,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Psilocybin has shown rapid and sustained antidepressant effects in patients with major depressive disorder, yet the neurobiological mechanisms underlying these outcomes remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>\n                      This study aimed to bridge clinical and preclinical findings by investigating the relationships between 5-HT\n                      <jats:sub>2A<\/jats:sub>\n                      receptor occupancy (RO) achieved after administration of psilocybin and its effects on behavior and markers of neuroplasticity in mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      5-HT\n                      <jats:sub>2A<\/jats:sub>\n                      RO was determined via displacement of [\n                      <jats:sup>3<\/jats:sup>\n                      H]MDL-100,907 in the prefrontal cortex (PFC). To relate RO with behavioral outcomes of psilocybin, we assessed the head twitch response (HTR) acutely and investigated behavior in the elevated zero maze (EZM) and forced swim test (FST) 20\u201324\u2009hours post-drug. Neuroplastic changes were assessed by measuring \u03b1-tubulin post-translational modifications (PTMs) and expression of key synaptic proteins in both the PFC and amygdala.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Psilocybin produced dose-dependent 5-HT\n                      <jats:sub>2A<\/jats:sub>\n                      RO (RO\u2085\u2080\u2009=\u20090.88\u2009mg\/kg) and an inverted-U dose\u2013response in HTR, with peak effects occurring between ~44% and 62% RO. Behaviorally, a 1.5\u2009mg\/kg dose increased the open areas ratio in the EZM, while 3\u2009mg\/kg reduced immobility in the FST, 20 and 24\u2009hours after dosing, respectively. Both dose levels shifted \u03b1-tubulin PTMs toward a more dynamic microtubule state and selectively increased synaptic marker expression in the PFC, not in the amygdala.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These findings suggest that the therapeutic effects of psilocybin could be mediated by dose- and region-specific enhancement of neuronal plasticity, with distinct signatures associated with anxiolytic-like and antidepressant-like properties.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811251395386","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:05:42Z","timestamp":1767701142000},"page":"81-94","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["An exploration of the relationships between the effects of psilocybin on behavior, 5-HT\n                    <sub>2A<\/sub>\n                    receptor occupancy, and neuroplastic effects in mice"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2746-9055","authenticated-orcid":false,"given":"Connor J.","family":"Maltby","sequence":"first","affiliation":[{"name":"Ulysses Neuroscience Ltd., Pioneer Life Sciences, Dublin, Republic of Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1640-9324","authenticated-orcid":false,"given":"Adam K.","family":"Klein","sequence":"additional","affiliation":[{"name":"Gilgamesh Pharmaceuticals, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enya","family":"Paschen","sequence":"additional","affiliation":[{"name":"Ulysses Neuroscience Ltd., Pioneer Life Sciences, Dublin, Republic of Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8859-5146","authenticated-orcid":false,"given":"Jessica","family":"Pinto","sequence":"additional","affiliation":[{"name":"Ulysses Neuroscience Ltd., Pioneer Life Sciences, Dublin, Republic of Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Dvorak","sequence":"additional","affiliation":[{"name":"Gilgamesh Pharmaceuticals, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Hedde","sequence":"additional","affiliation":[{"name":"Kesla Translational Models, Kingston, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Hanks","sequence":"additional","affiliation":[{"name":"Kesla Translational Models, Kingston, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-1816","authenticated-orcid":false,"given":"Massimiliano","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Ulysses Neuroscience Ltd., Pioneer Life Sciences, Dublin, Republic of Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-0944","authenticated-orcid":false,"given":"Zo\u00eb A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Gilgamesh Pharmaceuticals, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"e_1_3_2_2_1","first-page":"36","article-title":"Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice","volume":"4","author":"Andrade R","year":"2010","unstructured":"Andrade R, Weber ET (2010) Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice. Frontiers in Neuroscience 4: 36.","journal-title":"Frontiers in Neuroscience"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13033"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2018.03.001"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1847-10.2010"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.11.016"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121485109"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.06.005"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05170.x"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800705774322012"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.10230"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20614"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0540-6"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.2c00718"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4771-x"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032994"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology12040561"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2024.173917"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2018.10.021"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1963.tb01302.x"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3546"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2004.03.014"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12779-5"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41600-9"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.2c00170"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02414-5"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113612"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.07.018"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00087"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00237"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.01.008"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.112.19.3373"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.07.016"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.01.017"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3006-z"},{"key":"e_1_3_2_40_1","first-page":"159","article-title":"Effect of hallucinogens on unconditioned behavior","volume":"36","author":"Halberstadt AL","year":"2016","unstructured":"Halberstadt AL, Geyer MA (2016) Effect of hallucinogens on unconditioned behavior. Brain Imaging in Behavioral Neuroscience 36: 159\u2013199.","journal-title":"Brain Imaging in Behavioral Neuroscience"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107933"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110388326"},{"key":"e_1_3_2_43_1","article-title":"Harnessing psilocybin: Antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave N","year":"2021","unstructured":"Hesselgrave N, Troppoli TA, Wulff AB, et al. (2021) Harnessing psilocybin: Antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proceedings of the National Academy of Sciences of the United States of America 118: e2022489118.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00493"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi2403"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2821"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/417455a"},{"key":"e_1_3_2_48_1","first-page":"418","article-title":"P685. Functional and sexual disability and quality of life after one dose of MM120 (lysergide) in adults with generalized anxiety disorder","volume":"49","author":"Jacobsen P","year":"2024","unstructured":"Jacobsen P, Barrow R, Conant C, et al. (2024) P685. Functional and sexual disability and quality of life after one dose of MM120 (lysergide) in adults with generalized anxiety disorder. Neuropsychopharmacol 49: 418\u2013594.","journal-title":"Neuropsychopharmacol"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14188"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.11.013"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2019.15"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01783-1"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00176"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.06.063"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.213"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2597-5"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6871089"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-12-47"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.04.08.647810"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.022"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0324-9"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0350-2"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.22774"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(03)00038-8"},{"key":"e_1_3_2_65_1","first-page":"81","article-title":"Serotonin 2A receptor regulates microtubule assembly and induces dynamics of dendritic growth cones in rat cortical neurons in vitro","author":"Ohtani A","year":"2014","unstructured":"Ohtani A, Kozono N, Senzaki K, et al. (2014) Serotonin 2A receptor regulates microtubule assembly and induces dynamics of dendritic growth cones in rat cortical neurons in vitro. Neuroscience Research 81\u201382: 11\u201320.","journal-title":"Neuroscience Research"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.65"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-024-01454-4"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv119"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200902142"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.104.2.289"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.14530"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020835"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1133414"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2021.12.006"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-011-1078-9"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2018.05.004"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-024-01794-6"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqae083"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214148"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02477-w"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2021.06.008"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244871"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.9b01061"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.08.038"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116337"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02778-x"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620110-00002"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199812010-00024"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44016-1"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibneur.2022.09.001"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111243"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(99)00014-7"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2009.08.008"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2024.137870"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2013.11.033"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(01)00002-1"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251395386","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251395386","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251395386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:02:01Z","timestamp":1782205321000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251395386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/02698811251395386"],"URL":"https:\/\/doi.org\/10.1177\/02698811251395386","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}